Southern Med Law Is Representing Women In Power Morcellator Lawsuit Claims Alleging Laparoscopic Morcellation Spread Undiagnosed Uterine Cancer, Including Leiomyosarcoma, During Hysterectomies And Myomectomies.
As power morcellator lawsuit claims against Ethicon consolidate in Kansas disturbing finding in a new uterine morcellation study leaves concern. The new study found that The number of women who undergo gynecological surgery and are diagnosed with undetected uterine sarcoma, including leiomyosarcoma, may be higher than initially estimated by the U.S. Food and Drug Administration (FDA). morcellator cancer lawsuits have been filed on behalf of women who allege laparoscopic power morcellation used during a hysterectomy or a myomectomy to remove uterine fibroids spread undetected uterine cancer.
In April 2014, the FDA estimated 1 in 350 women who have uterine fibroids removed have undetected cancer. However, a study published in the American Journal of Obstetrics & Gynecology in May 2015 indicated that 1 in 156 women was found to have uterine cancer. Researchers reviewed records of 941 women who underwent a hysterectomy and myomectomy with power morcellation and found 10 of the 941 women were diagnosed with uterine sarcomas or parasitic myomas only after the surgery. The overall incidence of uterine sarcoma was 6 of 941, with a median age range of 41 to 52 years, according to the study.
[ajog.org/article/S0002-9378(14)02379-5/fulltext, American Journal of Obstetrics & Gynecology, May 2015]
Doctor and Attorney Francois Blaudea, of Southern Med Law, was the first to take on morcellator manufacturers by filing the first federal power morcellator lawsuit against LiNA Medical APS. The lawsuit involving a woman diagnosed with uterine cancer after a hysterectomy, was settled for an undisclosed amount. Southern Med Law is currently involved in morcellator lawsuit claims against Ethicon Inc., a subsidiary of Johnson & Johnson, which makes power morcellators. The firm believes morcellator manufacturers know that their devices can potentially disseminate undiagnosed uterine cancer and fail to publicly disclose this information.
Laparoscopic power morcellators used in a hysterectomy to remove the uterus or a myomectomy to remove uterine fibroids, have blades to grind up uterine tissue into fragments that are removed through small incisions in the abdomen. Uterine tissue containing undetected cancer cells can spread to other areas of the body if they are left in the abdomen. In April 2014, the FDA issued a morcellator cancer warning and discouraged doctors from using power morcellators due to their potential to disseminate cancer. Based on its analysis of currently available data, the FDA estimated that 1 in 350 women undergoing a hysterectomy or myomectomy has an unsuspected uterine sarcoma, including leiomyosarcoma, an aggressive type of cancer. The agency issued a stronger warning in November 2014, that all but banned using power morcellators in the majority of women undergoing a hysterectomy or myomectomy to treat uterine fibroids.
[fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm424443.htm, FDA, November 24, 2014]
Court documents indicate that a federal judicial panel recently consolidated at least 28 morcellator cancer lawsuits filed in federal courts nationwide against Ethicon Inc. The morcellator lawsuits are centralized in the U.S. District Court, District of Kansas for coordinated pretrial proceedings. Among the claims included in the consolidation is a case filed by a South Carolina man whose wife died of leiomyosarcoma in September 2014. According to the complaint, the woman underwent a total laparoscopic robotic power morcellation hysterectomy and cystoscopy in October 2012. The complaint alleges Ethicon’s power morcellator spread the cancer during the surgery. (Case No. 6:15-cv-00516, U.S. District Court, District of South Carolina)
Southern Med Law is a law firm who and strong advocate for people harmed by medical devices. The firms experienced attorneys providing legal representation to the victims of negligent personal injuries, medical malpractice, dangerous drugs, faulty medical devices and defective products. Led by Dr. François Blaudeau the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in all manner of product liability and personal injury claims. They’re not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.
Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
Medical Negligence/MedicalDevice/Pharma/Qui Tam